Прати
Yasar Caliskan
Yasar Caliskan
Saint Louis University School of Medicine
Верификована је имејл адреса на health.slu.edu
Наслов
Навело
Навело
Година
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens
K Kiryluk, Y Li, F Scolari, S Sanna-Cherchi, M Choi, M Verbitsky, D Fasel, ...
Nature genetics 46 (11), 1187-1196, 2014
6812014
The MEST score provides earlier risk prediction in lgA nephropathy
SJ Barbour, G Espino-Hernandez, HN Reich, R Coppo, ISD Roberts, ...
Kidney international 89 (1), 167-175, 2016
2972016
Corticosteroids in IgA nephropathy: a retrospective analysis from the VALIGA study
V Tesar, S Troyanov, S Bellur, JC Verhave, HT Cook, J Feehally, ...
Journal of the American Society of Nephrology 26 (9), 2248-2258, 2015
2502015
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis
J Xie, L Liu, N Mladkova, Y Li, H Ren, W Wang, Z Cui, L Lin, X Hu, X Yu, ...
Nature communications 11 (1), 1600, 2020
1762020
Diagnostic Pathology: Kidney Diseases E-Book
RB Colvin, A Chang, LD Cornell
Elsevier Health Sciences, 2023
1332023
Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients
A Ozkok, Y Caliskan, T Sakaci, G Erten, G Karahan, A Ozel, A Unsal, ...
Clinical journal of the American Society of Nephrology 7 (6), 965-973, 2012
1102012
Mycophenolate mofetil in combination with steroids for treatment of C3 glomerulopathy: a case series
RS Avasare, PA Canetta, AS Bomback, M Marasa, Y Caliskan, Y Ozluk, ...
Clinical Journal of the American Society of Nephrology 13 (3), 406-413, 2018
1072018
Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection
NJ Steers, Y Li, Z Drace, JA D’Addario, C Fischman, L Liu, K Xu, YJ Na, ...
New England Journal of Medicine 380 (20), 1918-1928, 2019
1002019
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy
K Kiryluk, E Sanchez-Rodriguez, XJ Zhou, F Zanoni, L Liu, N Mladkova, ...
Nature genetics 55 (7), 1091-1105, 2023
962023
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update
R Coppo, G D'Arrigo, G Tripepi, ML Russo, ISD Roberts, S Bellur, ...
Nephrology Dialysis Transplantation 35 (6), 1002-1009, 2020
942020
Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease
B Yelken, Y Caliskan, N Gorgulu, I Altun, A Yilmaz, H Yazici, H Oflaz, ...
Clinical nephrology 77 (4), 275, 2012
932012
Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever
N Alpay, A Şumnu, Y Çalışkan, H Yazıcı, A Türkmen, A Gül
Rheumatology international 32, 3277-3279, 2012
922012
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort
R Coppo, D Lofaro, RR Camilla, S Bellur, D Cattran, HT Cook, ...
Pediatric nephrology 32, 139-150, 2017
882017
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy
FP Schena, VW Anelli, J Trotta, T Di Noia, C Manno, G Tripepi, G D’Arrigo, ...
Kidney international 99 (5), 1179-1188, 2021
862021
Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience
A Ozkok, TS Akpinar, F Tufan, NA Kanitez, M Uysal, M Guzel, Y Caliskan, ...
Clinical and experimental nephrology 17, 345-351, 2013
762013
Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation
Y Caliskan, SK Besisik, D Sargin, T Ecder
Bone marrow transplantation 38 (2), 141-147, 2006
722006
Survey of US living kidney donation and transplantation practices in the COVID-19 era
KL Lentine, LS Vest, MA Schnitzler, RB Mannon, V Kumar, MD Doshi, ...
Kidney international reports 5 (11), 1894-1905, 2020
682020
The clinical significance of uric acid and complement activation in the progression of IgA nephropathy
Y Caliskan, Y Ozluk, D Celik, N Oztop, A Aksoy, AS Ucar, H Yazici, ...
Kidney and Blood Pressure Research 41 (2), 148-157, 2016
662016
Extrapulmonary tuberculosis in immunocompetent adults
AA Cagatay, Y Caliskan, S Aksoz, L Gulec, S Kucukoglu, Y Cagatay, ...
Scandinavian journal of infectious diseases 36 (11-12), 799-806, 2004
652004
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy
SJ Barbour, R Coppo, H Zhang, ZH Liu, Y Suzuki, K Matsuzaki, L Er, ...
Kidney international 102 (1), 160-172, 2022
642022
Систем тренутно не може да изврши ову радњу. Пробајте поново касније.
Чланци 1–20